
WuXi AppTec Sells China Clinical Research Business to Sharpen Focus
WuXi AppTec has agreed to sell its China-based clinical research services business, including WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management, as part of a strategic move to focus on its core business.







































